John C He Selected Research

John C He Research Topics

Disease

9	Diabetic Nephropathies (Diabetic Nephropathy) 10/2020 - 12/2013
7	Albuminuria 10/2021 - 01/2014
7	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 07/2021 - 01/2009
7	Kidney Diseases (Kidney Disease) 01/2021 - 05/2012
7	Proteinuria 12/2016 - 03/2011
5	Fibrosis (Cirrhosis) 12/2021 - 08/2008
5	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2019 - 09/2013
4	Inflammation (Inflammations) 01/2021 - 10/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2012
2	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 07/2021
2	Hyperglycemia 01/2021 - 02/2015
2	Insulin Resistance 10/2016 - 08/2008
2	Chronic Renal Insufficiency 07/2015 - 05/2008
2	IGA Glomerulonephritis (IGA Nephropathy) 11/2014 - 09/2013
1	COVID-19 07/2021
1	Disease Progression 01/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019
1	Wilms Tumor (Wilm's Tumor) 10/2018
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2017
1	Body Weight (Weight, Body) 10/2016
1	Reperfusion Injury 01/2016
1	Hypertrophy 02/2015
1	Diabetes Mellitus 07/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2014
1	Diabetes Complications 05/2014
1	Pre-Eclampsia (Preeclampsia) 01/2014
1	Glomerulonephritis 11/2013
1	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2013
1	Renal Insufficiency (Renal Failure) 05/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2012
1	Hypoxia (Hypoxemia) 01/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2008
1	Ischemia 05/2008
1	Hyperemia 05/2008

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2020 - 11/2014
4	Streptozocin (Streptozotocin)FDA Link 01/2020 - 04/2013
3	Differentiation AntigensIBA 10/2018 - 03/2011
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2018 - 03/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015 - 06/2012
2	CreatinineIBA 10/2021 - 10/2021
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2021 - 11/2013
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2020 - 05/2008
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 05/2013
2	Transcription Factors (Transcription Factor)IBA 10/2018 - 11/2017
2	GlucocorticoidsIBA 10/2018 - 01/2017
2	CateninsIBA 11/2017 - 05/2013
2	Messenger RNA (mRNA)IBA 11/2017 - 05/2008
2	Sirtuin 1IBA 10/2016 - 07/2014
2	Receptor for Advanced Glycation End ProductsIBA 10/2016 - 05/2008
2	LipopolysaccharidesIBA 01/2016 - 06/2012
2	Am 580 (Am580)IBA 05/2012 - 03/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2021
1	Apolipoprotein L1IBA 07/2021
1	InterleukinsIBA 07/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	GS-444217IBA 01/2021
1	JNK Mitogen-Activated Protein KinasesIBA 01/2021
1	histone H3 trimethyl Lys4IBA 01/2021
1	MAP Kinase Kinase Kinase 5IBA 01/2021
1	Activins (Activin)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019
1	Guanylate KinasesIBA 01/2019
1	Protein SIBA 01/2018
1	Pyruvate KinaseIBA 10/2017
1	EnzymesIBA 10/2017
1	Dietary Advanced Glycation End ProductsIBA 01/2017
1	PlasminogenIBA 12/2016
1	Lactoylglutathione LyaseIBA 10/2016
1	Epoprostenol ReceptorsIBA 01/2016
1	locked nucleic acidIBA 01/2016
1	Protein Isoforms (Isoforms)IBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Pharmaceutical PreparationsIBA 07/2015
1	Phosphotransferases (Kinase)IBA 06/2015
1	Insulin (Novolin)FDA Link 02/2015
1	NAD (NADH)IBA 07/2014
1	AlbuminsIBA 01/2014
1	nephrinIBA 01/2014
1	CXA-10IBA 12/2013
1	ProteomeIBA 09/2013
1	Connective Tissue Growth FactorIBA 05/2013
1	CytokinesIBA 05/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 04/2013
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 05/2012
1	RoflumilastIBA 05/2012
1	RetinoidsIBA 05/2012
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 03/2011
1	Mitogen-Activated Protein KinasesIBA 01/2009
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 08/2008
1	Advanced Glycation End ProductsIBA 05/2008

Therapy/Procedure

4	Therapeutics 01/2021 - 12/2013
3	Nephrectomy 10/2018 - 05/2014
1	Peritoneal Dialysis 01/2017
1	Highly Active Antiretroviral Therapy (HAART) 01/2012
1	Induced Hyperthermia (Thermotherapy) 05/2008